Spending 30 minutes on a treadmill or an elliptical machine a few times each week is not the key to a healthy lifestyle. What’s more important is getting out of your chair, or off the couch, and moving throughout the day – preferably at least once an hour. That’s the logic behind Anytime Fitness’ new “Every Step Counts” campaign – which features reserved parking spots for its members as far away as possible from the gym, in the far corners of the parking lot.
“We care what you do outside the gym every bit as much as when you’re inside one of our facilities,” said Chuck Runyon, CEO and co-founder of Anytime Fitness. “Three hours of rigorous exercise a week is great. But what you do during the other 165 hours each week will really determine whether you’re healthy or not. If you sit in a chair and stare at a computer screen for eight hours a day, without moving every hour or so, then research* shows you’re much more likely to develop a long list of preventable chronic diseases. Sitting too much is the new smoking.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7942951-anytime-fitness-every-step-counts/
Blue Plate® Mayonnaise, one of the country’s oldest and most beloved condiment brands, is shaking up the mayonnaise aisle with the industry’s first mayonnaise made with Greek yogurt. Blue Plate Light Mayonnaise with Greek Yogurt (Blue Plate Light Greek) features creamy, tangy Greek yogurt for a full-flavored light mayonnaise with half the fat and calories of traditional mayonnaise, plus one gram of protein per serving. The new Blue Plate Light Greek is in stores now, available in a 30-ounce jar and a 12-ounce squeeze bottle.
This is the first major product innovation in real mayonnaise since the introduction of olive oil more than five years ago. Consumer research shows that Greek yogurt has come into its own as a food super trend, and U.S. consumption is expected to reach $4 billion by 2019. Blue Plate Light Greek features a flavor that is perfectly proportioned to pair with sandwiches, salads and more. The added protein is yet another nutritious benefit not found in any other mayonnaise.
To view the multimedia release go to:
http://www.multivu.com/players/English/7740951-blue-plate-greek-mayo/
Volvo Cars presents a unique, complete system solution that makes it possible to integrate self-driving cars into real traffic – with ordinary people in the driver’s seat.
“We are entering uncharted territory in the field of autonomous driving,” says Dr Peter Mertens, Senior Vice President Research and Development of Volvo Car Group. “Taking the exciting step to a public pilot, with the ambition to enable ordinary people to sit behind the wheel in normal traffic on public roads, has never been done before.”
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7443851-volvo-first-self-driving-car-system/
University of St. Augustine for Health Sciences (USAHS), a leading graduate institution that emphasizes health and rehabilitative sciences education through innovative classroom education, is pleased to announce the installation of SafeGait 360° Balance and Mobility Trainer® on its Austin, Texas campus. The device, which was designed in collaboration with experts in physical therapy (PT) and occupational therapy (OT), works to mitigate the risk of injury from falls, protecting both the patient and therapist. In addition, SafeGait 360°’s dynamic fall protection (DFP) distinguishes between a patient’s intentional downward movement and when a patient is actually falling, which allows therapists to easily modify fall protection sensitivity to accommodate and challenge patients at varying stages of independence.
USAHS is one of the first higher education institutions in the nation to install this innovative body-weight support and fall protection system. In addition to conducting ground breaking research with patients and students, faculty members with extensive experience in body-weight treatments aim to open a clinic which will provide new treatment options to patients in the Austin community, and will begin seeing patients in October of this year.
To view the multimedia release go to:
http://www.multivu.com/players/English/7743851-usahs-safegait-360-physical-therapy/
While regular visits to the eye doctor and dentist are mainstays of preventive healthcare, less than one in four Americans have had their hearing checked in the past two years, according to a consumer survey by Wakefield Research on behalf of EPIC Hearing Healthcare (EPIC). And, while most people with poor vision own glasses or contacts to help them see better, only one in five people who could benefit from a hearing aid wears one.
“A lot of people aren’t aware how important preventive care is for their hearing health,” said William M. Luxford, M.D., medical director, House Clinic. “Regular, comprehensive hearing exams by an audiologist are the best way to establish a baseline for your hearing and ensure any hearing loss is caught early so further damage can be prevented or minimized and hearing can be improved as quickly as possible.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7823651-epic-healthy-hearing-habits/
When it comes to St. Jude Children’s Research Hospital®, you don’t have to fly, have superhuman strength or have laser vision to be a Hero. St. Jude Heroes are an exclusive group of dedicated athletes committed to running for a reason—raising funds and awareness to support the lifesaving mission of St. Jude Children's Research Hospital.
St. Jude Heroes receive fundraising tools and support, along with event-specific benefits. More importantly, they help kids diagnosed with cancer and other life-threatening diseases. Thanks to dedicated St. Jude Heroes and other supporters, families never receive a bill from St. Jude for treatment, travel, housing or food — because all a family should worry about is helping their child live.
St. Jude Children’s Research Hospital founder Danny Thomas once said, “Success has nothing to do with what you gain in life or accomplish for yourself. It's what you do for others.” This statement couldn’t be more accurate of St. Jude Heroes.
To view the multimedia release go to:
http://www.multivu.com/players/English/7579851-st-jude-rock-n-roll-nashville-marathon/
Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information services, commemorated its 50-year anniversary by awarding $150,000 in total grants to three organizations that share its goal to improve healthcare: The American Red Cross, the National Ovarian Cancer Coalition and Autism Speaks.
At a ceremony at the company’s flagship clinical laboratory in Teterboro, NJ, the company’s chairman, president and CEO Steve Rusckowski presented Health In Your Hands grants of $50,000 to representatives from each organization. Paul Brown, M.D., founder and former CEO of Quest’s predecessor company Metropolitan Pathology Laboratory, Inc. or MetPath, established in April, 1967, was also recognized at the event.
To view the multimedia release go to:
https://www.multivu.com/players/English/8080751-quest-diagnostics-50th-anniversary/
Soy consumption is up 14 percent since 2011,26 yet confusion lingers over soy’s role in everything from human health to food production. To clear up misperceptions, the United Soybean Board (USB) busts five common soy myths with science-backed facts on SoyConnection.com/soy-wisdom.
1) Eating soy does not increase breast cancer risk.
Clinical studies show soy isoflavone exposure does not adversely affect breast tissue as assessed by markers of breast cancer risk, such as breast cell proliferation.1–7 The American Institute for Cancer Research and the American Cancer Society say that women who have been diagnosed with breast cancer can safely consume soyfoods. In fact, the World Cancer Research Fund International has identified a link between soy consumption and an improved survival of breast cancer patients.8-9
“Not only does evidence indicate soyfoods may benefit women with breast cancer, but consuming soy when young helps prevent the onset of this disease later in life27-30,” stated Mark Messina, Ph.D., who has dedicated the past 30 years to understanding the health effects of soyfoods.
To view the multimedia release go to:
http://www.multivu.com/players/English/7877951-united-soybean-board-top-soy-myths/
In celebration of the National Dog Show Presented by Purina and the Thanksgiving holiday, Purina invites dog lovers across the world to share why they are thankful for their four-legged friends and how they show their thankfulness through its #DogThanking initiative.
Dog owners are encouraged to log onto Facebook, Twitter or Instagram to post photos or videos showing how they thank their beloved dogs by using the hashtag #DogThanking. For every original post submitted through November 27 using the hashtag and tagging @Purina, Purina will donate one dollar to the Canine Health Foundation—up to $50,000—to help further pet health research. Submitted videos, photos and posts may be featured during the National Dog Show Presented by Purina on Thanksgiving Day.
To view the multimedia release go to:
http://www.multivu.com/players/English/7971751-purina-thanksgiving-national-dog-show-dogthanking/
Altimetrik, a business transformation and technology solutions company is unveiling advanced IoT solutions that are set to revolutionize the manufacturing industry.
Manufacturing industry is faced with the challenge of digitally connecting its assets with systems and people, engineering and acting upon the data on the floor to achieve predictive maintenance, precision monitoring & remote management. Altimetrik's Enterprise IoT capabilities make operational intelligence real by connecting machine data to newer business insights & driving meaningful outcomes. Altimetrik has made significant investments in creating IoT specific Research & Innovation Labs which’ve helped the company become a frontrunner in IoT consulting and execution. Altimetrik has been identified among leading IoT solution providers for manufacturing by IDC
Altimetrik is among the new breed of technology companies driving its business model based on the three global mega trends of modernization – Digital, Connected Solutions and Consumer Technologies.
To view the multimedia release go to:
http://www.multivu.com/players/uk/7772051-altimetrik-future-of-enterprise-internet/
Palo Alto Networks® (NYSE: PANW), the next-generation security company, today announced the latest edition of its Application Usage and Threat Report (AUTR) completed by the Palo Alto Networks Unit 42 Threat Intelligence team.
The report, based on data from more than 7,000 enterprises worldwide, showcases real-world trends in enterprise application usage and critical developments in how attackers are attempting to infect organizations. It also offers practical recommendations for preventing cyberattacks.
Findings highlight the explosion in adoption of software as a service (SaaS) based applications, with the potential to introduce new security risks, or allow unauthorized access to sensitive data. Through the report, security organizations also gain insight into how long-standing and common attack vectors, such as email and executable files, continue to present challenges, as well as global application usage trends for high-risk categories, such as remote access applications.
To view the multimedia release go to:
http://www.multivu.com/players/English/7049352-palo-alto-networks-autr/
Boston Scientific (NYSE: BSX) has received U.S. Food and Drug Administration (FDA) approval for the SYNERGY™ Bioabsorbable Polymer Drug-Eluting Stent System (BP-DES) for the treatment of coronary artery disease.
With this FDA approval, Boston Scientific will commence commercialization of the first and only BP-DES in the U.S. Notably, both the drug coating and the polymer – which modulates drug release – are fully absorbed shortly after drug elution is complete at three months.
The SYNERGY Stent provides synchronized drug and polymer absorption. It is designed to enable more rapid and complete arterial healing, and to thereby reduce the risk of complications associated with long-term polymer exposure compared to currently-used drug-eluting stents (DES) with permanent polymers.
To view the multimedia release go to:
http://www.multivu.com/players/English/7223456-boston-scientific-fda-approval-synergy/
